Mild and Rapidly Improving Stroke Study
NCT02072681 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2175
Last updated 2021-07-15
Summary
The objective of this study is to determine the 90-day outcomes of mild and rapidly improving ischemic stroke.
Conditions
Sponsors & Collaborators
- collaborator OTHER
-
Genentech, Inc.
collaborator INDUSTRY -
University of Miami
lead OTHER
Principal Investigators
-
Jose G Romano, MD · University of Miami
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-31
- Primary Completion
- 2020-12-31
- Completion
- 2021-06-30
Countries
- United States
Study Locations
More Related Trials
-
Dabigatran Following Transient Ischemic Attack and Minor Stroke
NCT02295826 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Assess the Acute Safety and Functional Outcome and Recovery After STROKE: The FIRST Trial
NCT01092819 ·Status: COMPLETED
-
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
NCT03907046 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"
NCT02671461 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Survival and Outcome After Stroke
NCT01193569 ·Status: COMPLETED
-
IMPROVE Stroke Care- Developing and Optimizing Regional Systems of Stroke Care
NCT04242784 ·Status: COMPLETED
-
The PREVENTS Trial: The Preventing Recurrent Events in Veterans Navigating Transient Ischemic Attack (TIA) or Stroke Trial
NCT01020851 ·Status: COMPLETED ·Phase: NA
-
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation
NCT03021928 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of BIIB131 for Participants With Ischemic Stroke Between 4.5 and 24 Hours After Last Known Well
NCT05764122 ·Status: WITHDRAWN ·Phase: PHASE2
-
Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis
NCT06058130 ·Status: RECRUITING ·Phase: NA
-
Study on the Efficacy and Safety of T-02 for the Treatment for Acute Ischemic Stroke
NCT05342038 ·Status: WITHDRAWN ·Phase: NA
-
Pharmacogenomics in Stroke: Feasibility of CYP2C19 Testing
NCT06943586 ·Status: RECRUITING ·Phase: NA
-
Midodrine for Ischemic Stroke With Penumbra
NCT02383121 ·Status: WITHDRAWN
-
Transitional Care Program to Improve Risk Factors in Stroke Survivors
NCT06657235 ·Status: RECRUITING ·Phase: NA
-
Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Asia
NCT01750788 ·Status: COMPLETED
-
THE IMPACT- 24M TRIAL (IMPlant Augmenting Cerebral Blood Flow in Mild Strokes Trial 24 Hours From Stroke Onset)
NCT03551093 ·Status: COMPLETED ·Phase: NA
-
Stroke Treatment With Acute Reperfusion and Simvastatin
NCT01073007 ·Status: COMPLETED ·Phase: PHASE4
-
Imaging Guided Patient Selection for Interventional Revascularization Therapy
NCT00963989 ·Status: COMPLETED ·Phase: NA
-
Xarelto on Prevention of Stroke and Noncentral Nervous System Systemic Embolism in Treatment-naïve Asian Patients With Non-valvular Atrial Fibrillation
NCT03284762 ·Status: COMPLETED
-
TIMING of Oral Anticoagulant Therapy in Acute Ischemic Stroke With Atrial Fibrillation
NCT02961348 ·Status: COMPLETED ·Phase: NA
-
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
NCT03192215 ·Status: TERMINATED ·Phase: PHASE3
-
Pulse Endovascular ReperFUSION for Acute Ischemic Stroke
NCT06052969 ·Status: RECRUITING ·Phase: NA
-
HT-3951 vs. Placebo in Stroke Rehabilitation
NCT02530307 ·Status: TERMINATED ·Phase: PHASE2
-
Dabigatran Treatment Following Transient Ischemic Attack and Minor Stroke
NCT01769703 ·Status: COMPLETED ·Phase: PHASE2
-
Mayo Acute Stroke Trial for Enhancing Recovery
NCT00805792 ·Status: COMPLETED ·Phase: PHASE2